ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,461,110, issued on Nov. 4, was assigned to University of Connecticut (Farmington, Conn.).
"Methods for treating breast cancer and for identifying breast cancer antigens" was invented by David Han (Farmington, Conn.) and Veneta Qendro (Farmington, Conn.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are isolated compositions including at least 2 of mutant peptides selected from the group consisting of SEQ ID NOS: 1-149, or polypeptides comprising the mutant peptides; wherein the composition comprises mutant peptides encoded by 2 or more genes. Also disclosed are methods for personalized treatment of breast cancer involving creating a pept...